This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (247)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Aging/ Geriatrics  • Review  • Hypertension  • Alert me on articles by topic  Social Bookmarking   What's this?

Are -Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

A Systematic Review

Franz H. Messerli, MD; Ehud Grossman, MD; Uri Goldbourt, PhD

JAMA. 1998;279:1903-1907.

Objective.— To assess antihypertensive efficacy of -blockers and their effects on cardiovascular morbidity and mortality and all-cause morbidity compared with diuretics in elderly patients with hypertension.

Data Source.— A MEDLINE search of English-language articles published between January 1966 and January 1998 using the terms hypertension (drug therapy) and elderly or aged or geriatric, and cerebrovascular or cardiovascular diseases, and morbidity or mortality. References from identified articles were also reviewed.

Data Selection.— Randomized trials lasting at least 1 year, which used as first-line agents diuretics and/or -blockers, and reported morbidity and mortality outcomes in elderly patients with hypertension.

Data Synthesis and Results.— Ten trials involving a total of 16164 elderly patients (60 years) were included. Two thirds of the patients assigned to diuretics were well controlled on monotherapy, whereas less than a third of the patients assigned to -blockers were well controlled on monotherapy. Diuretic therapy was superior to -blockade with regard to all end points and was effective in preventing cerebrovascular events (odds ratio [OR], 0.61; 95% confidence interval [CI], 0.51-0.72), fatal stroke (OR, 0.67; 95% CI, 0.49-0.90), coronary heart disease (OR, 0.74; 95% CI, 0.64-0.85), cardiovascular mortality (OR, 0.75; 95% CI, 0.64-0.87), and all-cause mortality (OR, 0.86; 95% CI, 0.77-0.96). In contrast, -blocker therapy only reduced the odds for cerebrovascular events (OR, 0.75; 95% CI, 0.57-0.98) but was ineffective in preventing coronary heart disease, cardiovascular mortality, and all-cause mortality (ORs, 1.01, 0.98, and 1.05, respectively).

Conclusions.— In contrast to diuretics, which remain the standard first-line therapy, -blockers, until proven otherwise, should no longer be considered appropriate first-line therapy of uncomplicated hypertension in the elderly hypertensive patient.

From the Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, La (Dr Messerli); and Internal Medicine (Dr Grossman) and The Neufeld Cardiac Institute (Dr Goldbourt), The Chaim Sheba Medical Center, Tel-Hashomer, Israel.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTERS

-Blockers as First-Line Agents for Hypertension in the Elderly
M. J. Kendall, Jerome D. Cohen, Franz H. Messerli, Ehud Grossman, and Uri Goldbourt
JAMA. 1999;281(2):131-133.
EXTRACT | FULL TEXT  

-Blocker Therapy and Depression
Takeshi Terao, Franz H. Messerli, Ehud Grossman, Dennis T. Ko, Patricia R. Hebert, Jeptha P. Curtis, Harlan M. Krumholz, Artyom Sedrakyan, and Christopher S. Coffey
JAMA. 2002;288(15):1845-1846.
EXTRACT | FULL TEXT  

Losartan vs Atenolol in Prevention of Stroke and Cardiovascular Disease
Franz H. Messerli, Ehud Grossman, and Albert Fournier
JAMA. 2003;289(6):700-701.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Talking With Patients About Screening for Prostate Cancer
David S. Rosenthal, Gabriel Feldman, and Wendy Levinson
JAMA. 1999;281(2):133.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antihypertensive Efficacy of Aliskiren: Is Hydrochlorothiazide an Appropriate Benchmark?
Messerli and Bangalore
Circulation 2009;119:371-373.
FULL TEXT  

Beta-Blockers in Hypertension: Adding Insult to Injury
Kaplan
J Am Coll Cardiol 2008;52:1490-1491.
FULL TEXT  

Beta-Blockers for Primary Prevention of Heart Failure in Patients With Hypertension: Insights From a Meta-Analysis
Bangalore et al.
J Am Coll Cardiol 2008;52:1062-1072.
ABSTRACT | FULL TEXT  

Nebivolol: A new antihypertensive agent
Gray and Ndefo
Am J Health Syst Pharm 2008;65:1125-1133.
ABSTRACT | FULL TEXT  

Thiazide-Type Diuretics and {beta}-Adrenergic Blockers as First-Line Drug Treatments for Hypertension
Cutler and Davis
Circulation 2008;117:2691-2705.
FULL TEXT  

Risk/Benefit Assessment of {beta}-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension
Messerli et al.
Circulation 2008;117:2706-2715.
FULL TEXT  

Cardiovascular Protection Using Beta-Blockers: A Critical Review of the Evidence
Bangalore et al.
J Am Coll Cardiol 2007;50:563-572.
ABSTRACT | FULL TEXT  

REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
Rosendorff et al.
Hypertension 2007;50:e28-e55.
FULL TEXT  

Prevention of Stroke and Myocardial Infarction by Amlodipine and Angiotensin Receptor Blockers: A Quantitative Overview
Wang et al.
Hypertension 2007;50:181-188.
ABSTRACT | FULL TEXT  

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Authors/Task Force Members: et al.
Eur Heart J 2007;0:ehm236v1-75.
FULL TEXT  

Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
Rosendorff et al.
Circulation 2007;115:2761-2788.
FULL TEXT  

Do {beta}-blockers have a role in treating hypertension?: YES
Khan and McAlister
cfp 2007;53:614-617.
FULL TEXT  

Les betabloquants ont-ils un role dans le traitement de l'hypertension?: OUI
Khan and McAlister
cfp 2007;53:618-621.
FULL TEXT  

Do {beta}-blockers have a role in treating hypertension?: NO
McCormack
cfp 2007;53:614-617.
FULL TEXT  

Les betabloquants ont-ils un role dans le traitement de l'hypertension?: NON
McCormack
cfp 2007;53:618-621.
FULL TEXT  

Blood pressure and ageing
Pinto
Postgrad. Med. J. 2007;83:109-114.
ABSTRACT | FULL TEXT  

Abnormal Pressure Passive Dilatation of Cerebral Arterioles in the Elderly With Isolated Systolic Hypertension
Castellani et al.
Hypertension 2006;48:1143-1150.
ABSTRACT | FULL TEXT  

Drug-disease interactions: losartan effect is not downregulated by rheumatoid arthritis.
Daneshtalab et al.
J Clin Pharmacol 2006;46:1344-1355.
ABSTRACT | FULL TEXT  

Clinical trials in hypertension.
Messerli et al.
JAMA 2006;296:1463-1463.
FULL TEXT  

Have ALLHAT, ANBP2, ASCOT-BPLA, and So Forth Improved Our Knowledge About Better Hypertension Care?
Sawicki and McGauran
Hypertension 2006;48:1-7.
FULL TEXT  

Re-examining the efficacy of {beta}-blockers for the treatment of hypertension: a meta-analysis
Khan and McAlister
CMAJ 2006;174:1737-1742.
ABSTRACT | FULL TEXT  

Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension
Khan et al.
CMAJ 2005;173:865-867.
FULL TEXT  

When premature is not premature--the ASCOT study
Messerli and Sichrovsky
Eur Heart J 2005;26:1822-1823.
FULL TEXT  

Cardiovascular Morbidity and Mortality in Hypertensive Patients With Lower Versus Higher Risk: A LIFE Substudy
Franklin et al.
Hypertension 2005;46:492-499.
ABSTRACT | FULL TEXT  

Hypertension Management in the Elderly Has Improved: Ontario Prescribing Trends, 1994 to 2002
Tu et al.
Hypertension 2005;45:1113-1118.
ABSTRACT | FULL TEXT  

Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness
Zieman et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:932-943.
ABSTRACT | FULL TEXT  

Recent hypertension trials: Implications and controversies
Williams
J Am Coll Cardiol 2005;45:813-827.
ABSTRACT | FULL TEXT  

Association of Intentional Changes in Body Weight with Coronary Heart Disease Event Rates in Overweight Subjects Who Have an Additional Coronary Risk Factor
Eilat-Adar et al.
Am J Epidemiol 2005;161:352-358.
ABSTRACT | FULL TEXT  

Systolic Hypertension in Older Persons
Chaudhry et al.
JAMA 2004;292:1074-1080.
ABSTRACT | FULL TEXT  

A putative placebo comparison of the SCOPE and LIFE trials
Meredith et al.
Journal of Renin-Angiotensin-Aldosterone System 2004;5:59-63.
ABSTRACT  

A Calcium Antagonist vs a Non-Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease: The International Verapamil-Trandolapril Study (INVEST): A Randomized Controlled Trial
Pepine et al.
JAMA 2003;290:2805-2816.
ABSTRACT | FULL TEXT  

ALLHAT, or the Soft Science of the Secondary End Point
Messerli
ANN INTERN MED 2003;139:777-780.
ABSTRACT | FULL TEXT  

The LIFE study: the straw that should break the camel's back
Messerli
Eur Heart J 2003;24:487-489.
FULL TEXT  

Outcome beyond blood pressure control?
Staessen et al.
Eur Heart J 2003;24:504-514.
FULL TEXT  

Losartan vs Atenolol in Prevention of Stroke and Cardiovascular Disease
Messerli et al.
JAMA 2003;289:700-701.
FULL TEXT  

{beta}-Blocker Therapy and Depression
Terao et al.
JAMA 2002;288:1845-1846.
FULL TEXT  

Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy: A Losartan Intervention For Endpoint Reduction (LIFE) Substudy
Kjeldsen et al.
JAMA 2002;288:1491-1498.
ABSTRACT | FULL TEXT  

Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients
Krum et al.
Hypertension 2002;40:117-123.
ABSTRACT | FULL TEXT  

Evaluation and Treatment of Patients With Systemic Hypertension
Garg et al.
Circulation 2002;105:2458-2461.
FULL TEXT  

Therapy in the elderly hypertensive
Meredith and Trenkwalder
Journal of Renin-Angiotensin-Aldosterone System 2002;3:S49-S56.
ABSTRACT  

Guidelines for the Management of Patients with Chronic Stable Angina: Treatment
Fihn et al.
ANN INTERN MED 2001;135:616-632.
ABSTRACT | FULL TEXT  

Diabetes, Hypertension, and Cardiovascular Disease: An Update Response
Messerli et al.
Hypertension 2001;38 :e11-e11.
FULL TEXT  

Drug treatment of isolated systolic hypertension
van Zwieten
Nephrol Dial Transplant 2001;16:1095-1097.
FULL TEXT  

Evidence based management of hypertension: What are the elements of good treatment for hypertension?
Mulrow and Pignone
BMJ 2001;322:1107-1109.
FULL TEXT  

Lowering blood pressure in particular patient groups
DTB 2001;39:37-40.
ABSTRACT | FULL TEXT  

Review: The management of the elderly with hypertension
Bulpitt
Journal of Renin-Angiotensin-Aldosterone System 2001;2:11-13.
 

Hypothesis: {beta}-Adrenergic Receptor Blockers and Weight Gain : A Systematic Analysis
Sharma et al.
Hypertension 2001;37:250-254.
ABSTRACT | FULL TEXT  

Recent advances: Geriatric
BMJ 2001;322:86-89.
FULL TEXT  

Antihypertensive Drug Therapies and the Risk of Ischemic Stroke
Klungel et al.
Arch Intern Med 2001;161:37-43.
ABSTRACT | FULL TEXT  

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial
Black et al.
Hypertension 2001;37:12-18.
ABSTRACT | FULL TEXT  

High Blood Pressure and Diabetes Mellitus: Are All Antihypertensive Drugs Created Equal?
Grossman et al.
Arch Intern Med 2000;160:2447-2452.
ABSTRACT | FULL TEXT  

Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 2: {beta}-Blockers
Wright
CMAJ 2000;163:188-192.
ABSTRACT | FULL TEXT  

Trends in Antihypertensive Drug Treatment Response
Opie et al.
Circulation 2000;101 :e209-e209.
FULL TEXT  

Controlling hypertension in the elderly
Bulpitt
QJM 2000;93:203-205.
FULL TEXT  

Angiotensin-Converting Enzyme Inhibitor-Associated Elevations in Serum Creatinine: Is This a Cause for Concern?
Bakris and Weir
Arch Intern Med 2000;160:685-693.
ABSTRACT | FULL TEXT  

Beta-blockers continue to surprise us
Cruickshank
Eur Heart J 2000;21:354-364.
 

Prevalence, Treatment, and Control of Hypertension by Sociodemographic Factors Among the Dutch Elderly
van Rossum et al.
Hypertension 2000;35:814-821.
ABSTRACT | FULL TEXT  

Management of hypertension
Wilding et al.
BMJ 2000;320:576-576.
FULL TEXT  

Hypertension in the Elderly: Can We Improve Results of Therapy?
Prisant and Moser
Arch Intern Med 2000;160:283-289.
ABSTRACT | FULL TEXT  

The necessity for recognition and treatment of patients with "mild" hypertension
Frohlich
J Am Coll Cardiol 1999;34:1369-1377.
ABSTRACT | FULL TEXT  

The Use of Sublingual Nifedipine: A Continuing Concern
Messerli and Grossman
Arch Intern Med 1999;159:2259-2260.
FULL TEXT  

British Hypertension Society guidelines for hypertension management 1999: summary
Ramsay et al.
BMJ 1999;319:630-635.
FULL TEXT  

Antihypertensive Therapy in the Elderly: Evidence-Based Guidelines and Reality
Messerli et al.
Arch Intern Med 1999;159:1621-1622.
FULL TEXT  

National Recommendations for the Pharmacological Treatment of Hypertension: Should They Be Revised?
Moser
Arch Intern Med 1999;159:1403-1406.
FULL TEXT  

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
Gibbons et al.
J Am Coll Cardiol 1999;33:2092-2197.
FULL TEXT  

Advances in the Treatment of Hypertension
Pickering
JAMA 1999;281:114-116.
FULL TEXT  

{beta}-Blockers as First-Line Agents for Hypertension in the Elderly
Kendall et al.
JAMA 1999;281:131-133.
FULL TEXT  

Beta-Blockers Ineffective for Hypertension in the Elderly
Journal Watch Cardiology 1998;1998:2-2.
FULL TEXT  

Are Beta-Blockers Helpful in the Elderly?
JWatch General 1998;1998:2-2.
FULL TEXT